This interview with CEO Dr. Michelle Miller presents an excellent overview of the state of the company and the market (although even in the 4 months since there has been significant advances in treatment trials)
http://www.youtube.com/watch?v=M3-W2XVKR0g
Surely Gilead will not be able to dominate a multi billion dollar market opportunity for long and hopefully BIT-225 is part of a treatment regime that picks up a share of the pie.
....and don't underestimate the HIV treatment potential
I'm with you Denton, here's cheers to all the longtermers right back to Tawny Port many years ago.
GLTA
FF
this should have a market cap of 100 million +, page-37
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.003(9.09%) |
Mkt cap ! $27.06M | |||
| Open | High | Low | Value | Volume |
| 3.3¢ | 3.4¢ | 3.0¢ | $32.26K | 1.016M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 720804 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| BIT (ASX) Chart |